Sadia Jahan

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Day-care management of severe and very severe pneumonia, without associated co-morbidities such as severe malnutrition, in an urban health clinic in Dhaka, Bangladesh

Hasan Ashraf, Sadia Jahan, Nur Alam et al. · Archives of Disease in Childhood · 2007 · 25 citations

T‐cell adoptive immunotherapy for BK nephropathy in renal transplantation

Sadia Jahan, Carla Scuderi, Leo Francis et al. · Transplant Infectious Disease · 2020 · 22 citations · Full text

Use of herbal medicines during pregnancy in a group of Bangladeshi women

Sadia Jahan, Zannatul Mamnuna Mozumder, Diponkor Kumar Shill · Heliyon · 2022 · 19 citations · Full text